SYNOVIAL SARCOMA
Clinical trials for SYNOVIAL SARCOMA explained in plain language.
Never miss a new study
Get alerted when new SYNOVIAL SARCOMA trials appear
Sign up with your email to follow new studies for SYNOVIAL SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy trial offers hope for Tough-to-Treat sarcomas
Disease control Recruiting nowThis early-stage study is testing a new treatment for people with advanced synovial sarcoma or myxoid/round cell liposarcoma. Researchers are giving patients donated immune cells (NK cells) that have been specially engineered to find and attack cancer. The main goals are to find …
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New oral drug trial offers hope for rare, Tough-to-Treat sarcomas
Disease control Recruiting nowThis study is testing an oral medication called anlotinib for people with advanced forms of soft tissue sarcoma that have spread or cannot be removed by surgery. The main goal is to see if the drug can shrink tumors or slow their growth compared to standard chemotherapy. The tria…
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE3 • Sponsor: Advenchen Laboratories, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Last-Chance cancer therapy offered when standard product fails specs
Disease control AVAILABLEThis program provides controlled access to a special version of a cell therapy (afami-cel) for patients with synovial sarcoma or myxoid liposarcoma when the standard manufactured product does not meet quality specifications. It is for patients who have already been prescribed thi…
Matched conditions: SYNOVIAL SARCOMA
Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
First human test of Dual-Attack cancer therapy begins
Disease control Recruiting nowThis is a first-in-human study to test the safety and early effectiveness of a two-part treatment called IMA203 combined with mRNA-4203. It is for people with advanced skin cancer (melanoma) or a rare soft-tissue cancer (synovial sarcoma) that has spread and no longer responds to…
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1 • Sponsor: Immatics US, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:19 UTC
-
Scientists reprogram immune cells to hunt deadly sarcomas
Disease control Recruiting nowThis early-stage study is testing the safety of a two-part treatment for advanced sarcomas that have stopped responding to standard therapies. Doctors take a patient's own immune cells, genetically modify them to recognize and attack cancer cells, and then infuse them back. These…
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New hope for kids with tough cancers: trial tests 'Living Drug'
Disease control Recruiting nowThis study is testing a new personalized cell therapy called afamitresgene autoleucel in children and young adults with advanced cancers like sarcoma and neuroblastoma. The main goals are to see if the treatment is safe and if it can shrink tumors. Researchers will enroll up to 2…
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
New hope for kids with aggressive cancers: trial tests supercharged immune transplant
Disease control Recruiting nowThis study is testing a new type of stem cell transplant for children and young adults whose solid tumors have returned or not responded to standard treatments. Doctors are using a donor's stem cells that have been specially processed to remove certain immune cells, then combinin…
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC